News

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
Because chronic inflammation is key to aging, Ozempic’s anti-inflammatory effects (among others) make it a powerful ...
Otto’s, a French restaurant in London known for rich feasts of canard à la presse, lobster soufflé and crêpes suzette, introduced a “menu for one, small appetite” in May. The tasting menu, which costs ...
Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...
Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...
Kids and teens who spend more time on screens and get less sleep may have higher risks for future heart and metabolic ...
Among US adolescents, current medical use of prescription stimulants for ADHD increased between 2005 and 2023, while nonmedical use decreased.
GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...
OPENING my 10th can of cola of the day and gorging on a Chinese takeaway, I felt utterly miserable. Weighing 29st and a size ...
Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...
Despite concerns about increased stimulant prescribing, nonmedical use of ADHD drugs among adolescents has declined in the last 20 years, a University of Michigan study shows.